HOME >> BIOLOGY >> NEWS
Univ. of Pittsburgh Medical Center leads group buying PPL'S cloning, stem cell business

and inexpensively. We are indeed positioned to develop technologies that will have a significant impact on people's lives," said Jeffrey Romoff, president of UPMC.

In addition to UPMC, other key investors are Highmark Health Ventures Investment Fund of Pittsburgh; Fujisawa Investments for Entrepreneurship, LP; and Fujisawa Investments for Entrepreneurship II, LP, of Wilmington, Del.

By partnering with the renowned research teams from UPMC and the University of Pittsburgh's Thomas E. Starzl Transplantation Institute, which has been working with PPL for the past three years, Regenecor plans to leverage PPL's scientific advancements in stem cells, xenotransplantation and immune tolerance technologies with an initial focus on developing treatments for diabetes and pursuing whole organ transplantation using animal organs.

Existing federal funding from the National Institute of Standards and Technology's Advanced Technology Program will support the production and differentiation of stem cells from non-human primates and livestock species, and a multi-year contract with the U.S. Department of Defense's Defense Advanced Research Projects Agency will allow continued support of the polyclonal antibodies program for biological warfare countermeasures.

It is anticipated that collaborations will be developed in all three technology areas similar in nature to the fruitful one that has existed between PPL and the Starzl Transplantation Institute since April 2000.

Starzl Transplantation Institute researchers first joined forces with PPL's xenotransplantation team following PPL's creation in March 2000 of the world's first cloned pigs. Chief among the Pittsburgh researchers was Chihiro Koike, M.D., Ph.D., assistant professor of surgery, whose gene sequencing work contributed a key understanding that allowed PPL to move forward and achieve two more significant milestones involving the creation of cloned pigs lacking the gene associated wi
'"/>

Contact: Lisa Rossi
412-647-3555
University of Pittsburgh Medical Center
9-Apr-2003


Page: 1 2 3 4 5

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Univ. of Pittsburgh receives $6.3M NIH grant to study oral health disparities in Appalachia
3. Univ. of Fla. professor: Air cleaning system destroys Anthrax, other pathogens
4. University of Pittsburgh receives $10 million grant for head and neck cancer
5. University of Pittsburgh medical center among first to implant heart assist device
6. University of Pittsburgh receives NIH funding to develop heart assist device for infants
7. Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon
8. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
9. Pittsburgh researchers engineer and successfully test SARS corona vaccine in animal model
10. Protein biomarkers accurately and quickly diagnose ALS, find Pittsburgh researchers
11. University of Pittsburgh scientist honored for major accomplishment in cancer research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... SAN DIEGO (PRWEB) , ... January 16, 2019 , ... ... building and cooking events company. Not only has the company already hosted several ... to host Fortune 500 companies, Amazon and Janssen Pharmaceuticals, later this month. , ...
(Date:1/10/2019)... ... ... Dr. Beanlands is the Vered Chair and Division Head of Cardiology at the ... of its National Cardiac PET Centre, and Professor in the University's Division of Cardiology ... of Cellular and Molecular medicine. , He is a founding member of ASNC, member ...
(Date:1/8/2019)... and RALEIGH, N.C. (PRWEB) , ... January 07, ... ... micro acoustic and micro mechanical technologies and solutions for hearing instruments and specialty ... today announced BiometRIC, the first ever hearing aid receiver in canal with an ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first ... up of industry leaders identified by the ASGCT board of directors. In total, the ... support ASGCT members designing transformative pilot studies in gene and cell therapy as they ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection ... changes in regulations in the European Union (EU) on the horizon, Jim Kasic, president ... , “The transition to the EU Medical Device Regulation (MDR), digital health, and big ...
(Date:12/18/2018)... ... 17, 2018 , ... ABCT , the Accelerator for ... to participate in the annual program. Twelve ventures will participate in the 6.5-month-long ... network. All startups receive an entrepreneur coach, access to active business professionals and ...
Breaking Biology Technology:
Cached News: